WHO Confirms Measles Has Reappeared in U.S. After 25‑Year Absence

Officials from the World Health Organization have verified that measles has resurfaced in the United States, breaking a period of over 25 years without native transmission. This conclusion comes after a handful of imported infections triggered small, localized outbreaks in multiple states.

The U.S. earned measles‑free certification in 2000 after more than a year of uninterrupted domestic absence, a success attributed to robust vaccination coverage, diligent monitoring and rapid public‑health responses that held the virus at arm’s length for three decades.

Current probes trace the latest flare‑ups to travelers coming back from measles‑endemic areas, especially certain locales in Europe and Asia. Over the last half‑year, health agencies in New York, California and Texas have recorded clusters linked to unvaccinated children and adults who acquired the disease overseas.

Specialists attribute the comeback to pockets of under‑immunized groups, frequently resulting from vaccine hesitancy, religious exemptions, or barriers to health care. The CDC points out that nationwide two‑dose MMR coverage has dipped marginally, giving the virus an opening.

In response, officials are rolling out focused immunization campaigns, school‑based clinics and heightened contact‑tracing measures. The WHO calls on every country to maintain at least 95 % two‑dose MMR coverage to safeguard herd immunity and prevent additional spillover.

While the outbreaks stay confined geographically, the situation highlights how illnesses once deemed eliminated can reappear when vaccination gaps expand. Officials emphasize that timely immunization remains the most dependable way to keep measles out of communities and to regain the United States’ disease‑free status.

Federal health bodies are reassessing school‑entry vaccine mandates and considering stricter exemption policies. Bills in multiple states seek to limit non‑medical exemptions, a move backed by numerous epidemiologists who contend that tighter rules could close the immunity gaps that allowed the present resurgence.